Skip to main content
. 2018 Jul 26;13(7):e0200936. doi: 10.1371/journal.pone.0200936

Fig 2. Subgroup analyses of disease-specific survival of 250 patients with lymph node-positive breast cancer according to preoperative systemic inflammatory markers.

Fig 2

An elevated neutrophil-lymphocyte ratio (NLR) (A), derived neutrophil-lymphocyte ratio (dNLR) (B), and platelet-lymphocyte ratio (PLR) (C) predicted poor disease-specific survival following surgical resection. A low lymphocyte-monocyte ratio (LMR) (D) predicted poor disease-specific survival. These results aligned with the results of a previous analysis performed with all 661 patients.